DermatologyTimes®: Advancing the science of skincare
Topicals aimed at reviving estrogen-deficient skin and warding off damage from UV rays hours after exposure, while repairing DNA, are among the new cosmeceutical innovations backed by science.
Emepelle (Biopelle) Serum and Night Cream feature methyl estradiolpropanoate (MEP) technology, which has estrogen like cutaneous effects. Dermatologist Joel L. Cohen, M.D., conducted a not-yet-published 20-week open-label trial looking at using the daytime Serum and Night Cream products.